Top News

Press Release | September 22, 2016

Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued a statement after introduction of bipartisan legislation in the U.S. Senate designed to ensure Medicare beneficiary access to needed medical technologies and services.

Press Release | September 20, 2016

WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, issued the following statement on today’s Senate HELP Committee hearing on laboratory testing in the era of precision medicine:

Press Release | September 12, 2016

Lima, Peru – Christopher L. White, senior executive vice president and general counsel of AdvaMed (the Advanced Medical Technology Association), issued the following statement following the Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized Companies Forum:


October 4, 2016 |

1:00 - 2:00 PM EST

The ability to communicate well is every business leader’s primary tool. Why do some speakers always win over the audience, while others fail to connect? Most speakers... Read More

October 12, 2016 | Virtual Webinar

­­­­­­­Recalls bring a unique set of questions, goals and demands to each stakeholder – from urgency to control of the narrative, overtaxing the internal systems, and minimizing the disruption in... Read More

Industry News

Little Falls, NJ - Cantel Medical Corp.
CANTEL MEDICAL CORP. (NYSE:CMN), a leading global company dedicated to delivering innovative infection prevention products and services, today announced that the Company has expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd. The endoscope reprocessing business consists of Cantel’s Medivators®-branded automated endoscope reprocessors, chemistries,...
Little Falls, NJ - Cantel Medical Corp.
(NYSE:CMN) announced today the appointment of Jorgen B. Hansen as the Company’s President and Chief Executive Officer, effective today, consistent with the Company’s long-term CEO succession plan. Mr. Hansen also will become a member of the Board of Directors. Mr. Hansen succeeds Andrew A. Krakauer, who will serve as a Senior Advisor for the Company until October 15, 2016.
Cohera Medical Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Sylys® Surgical Sealant device.
Fox News Channel
Heart disease is the number one cause of death for both men and women in the United States. Claiming approximately 1 million lives per year, heart attacks alone strike someone every 43 seconds. On January 20, 2014, that someone was me.
Opioid addiction, abuse, and overdose are at the forefront of our national dialogue. But by casting opioids as the villain, this important conversation is missing an essential element: how best to treat the chronic pain that afflicts 100 million Americans, including many of our wounded warriors. Chronic pain is a multifaceted problem with a range of causes and solutions, not a two-dimensional condition that can only be treated with opioids.

Twitter Feed

September 29, 2016 - 4:03pm
RT : Join ACLA & for the first-of-its-kind West Coast this fall in San Diego. Learn more:
September 29, 2016 - 12:45pm
Patient summit highlights importance of innovation in treating patients